60-Day Review Window Gives GaN Buyers Time to Check Approved Sources
A reported gallium nitride import ruling gives buyers a practical review window rather than a reason to rush. Evertiq reported on May 13, 2026 that the U.S. International Trade Commission affirmed an earlier ruling involving Infineon and Innoscience and that import and sales bans for Innoscience gallium nitride products in the United States are subject to a 60-day presidential review period before taking effect.
For sourcing teams, the practical issue is the 60-day review period described in the public report. That window can be used to check whether any approved GaN device, power stage, power-management path, or alternate source in an active BOM depends on a supplier path that needs closer review. That is a reason to check the sourcing file. It is not a reason to assume all GaN power devices are constrained, interchangeable, or safe to substitute without review.
What the 60-day window changes for sourcing
Evertiq’s report describes a final ITC decision in favor of Infineon in a GaN patent dispute with Innoscience. The report says the commission affirmed a prior determination, ordered import and sales bans for the named Innoscience gallium nitride products in the United States, and noted the 60-day presidential review period.
Those details matter because GaN devices are not generic commodities in many designs. They can sit in power supplies, adapters, data-center power conversion, industrial equipment, automotive-related platforms, and other high-efficiency power paths where switching behavior, thermal design, package choice, gate-drive assumptions, and qualification history all matter.
The safe buyer takeaway is simple: use the review period to identify named-part exposure and approved-source dependencies. Do not turn it into a general market conclusion unless additional public evidence shows broader availability, pricing, or lead-time impact.
What this means for PCX buyers with GaN on the AML
For PCX buyers, this is an approved-manufacturer-list review item. If a design uses GaN power devices, the buyer should know which manufacturer names, MPNs, alternates, packages, and approved vendor list entries are tied to the program. The sourcing team should also know whether purchasing has freedom to quote substitutes or whether engineering, quality, or customer approval is required first.
That distinction is especially important for discrete semiconductors and power management ICs, where electrical performance, thermal margin, packaging, and application history can matter as much as nominal voltage or current ratings. A part that looks similar in a distributor search may not be a drop-in replacement for a released design.
This is also where a sourcing partner can help keep the conversation disciplined. PCX can support availability checks and sourcing options, but the buyer’s file should make clear which evidence has to come with the quote and which changes require engineering review.
Where approved-source risk could appear
The most likely exposure is not “GaN is unavailable.” It is a smaller set of approved-source questions that can become urgent if they are not answered while the review window is still open:
- Approved-source exposure: Is the program dependent on a specific manufacturer, series, or package that may be affected?
- Alternate status: Are alternates already qualified, or are they only engineering possibilities?
- Regional supply path: Does the build require parts entering a market where the reported order could matter?
- Documentation: What traceability, date-code, lot, packaging, and inspection expectations should follow any sourced material?
- Customer or regulatory constraints: Are there customer approvals, production part approval requirements, or other program-specific rules that purchasing cannot change on its own?
None of those checks require legal conclusions from procurement. They require a clean separation between what the public report says, what the BOM actually uses, and what the released design allows.
What to verify before the review period closes
Before the review period closes, buyers should ask for the information that reduces confusion later. Confirm the exact MPNs and manufacturer names in the BOM. Check the approved manufacturer list and whether any alternate is released, conditionally approved, or still an engineering candidate. Ask whether open orders, forecasts, or scheduled releases depend on a source that may be affected by the reported ruling.
Then decide what evidence should accompany any quote. For power semiconductors, that may include traceability expectations, packaging condition, lot or date-code requirements, country-of-origin information where relevant to the program, and inspection requirements. When urgency increases, PCX’s Star Quality Control Program is a useful context for keeping verification and documentation in the sourcing conversation rather than treating them as afterthoughts.
The goal is not to slow the buyer down. It is to prevent a fast purchase from creating a qualification, documentation, or production-release problem later.
PM buyer takeaway
This is a watch item for GaN and power-electronics buyers, not a broad market alarm. If a program depends on a named GaN device family or narrow approved-source path, use the reported review window to confirm exposure, released alternates, evidence requirements, and escalation rules.
If you need help checking availability or building a disciplined sourcing path for affected power-device lines, send PCX an RFQ with the exact MPNs, approved alternates, and any quality or documentation requirements attached.